hepatitis C

Drug therapy effective in hepatitis C

A once daily drug combination of sofosbuvir-velpatasvir for 12 weeks resulted in sustained eradication of several genotypes of the hepatitis C virus in 99% of patients in a…
hepatitis c fda

FDA approves new treatment for hepatitis C

On July 18, the U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or…
FDA approves new treatment for hepatitis C

FDA approves new treatment for hepatitis C

August 3, 2017 – The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without…

Hepatitis C: Updates and beyond

In October 2021, the Infectious Diseases Society of America (IDSA) and the American Association for the Study of Liver Diseases (AASLD) updated their hepatitis C virus (HCV) guidelines…
reader feedback 2019

Reader Feedback, January 2019

THIS IS WHERE we share some of the comments, insights, and thoughts we receive from readers. Contact us at myamericannurse.com/send-letter-editor. (more…)
screening management hepatitis-c

Screening and management of hepatitis C

Use education to dispel the myths about the disease and increase screening and treatment. Takeaways:  Hepatitis C infection is a significant public health issue in the United States. …

WHO releases new hepatitis C guidelines

The World Health Organization (WHO) has released “Guidelines for the screening, care and treatment of persons with hepatitis C infection.” Access the guidelines.

Reader Survey

Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.

Survey

Test Your Knowledge

Cannabis TYK

Which of the following best explains why clinicians face challenges in discussing medicinal marijuana with their patients?

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.